Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase - PubMed (original) (raw)
Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase
H A Kim et al. Mol Cell Biol. 1997 Feb.
Abstract
We have developed a potential model of Schwann cell tumor formation in neurofibromatosis type 1 (NF1). We show that mouse Schwann cells heterozygous or null at Nf1 display angiogenic and invasive properties, mimicking the behavior of Schwann cells from human neurofibromas. Mutations at Nf1 are insufficient to promote Schwann cell hyperplasia. Here we show that Schwann cell hyperplasia can be induced by protein kinase A activation in mutant cells. Removal of serum from the culture medium also stimulates hyperplasia, but only in some mutant cells. After serum removal, clones of hyperproliferating Schwann cells lose contact with axons in vitro, develop growth factor-independent proliferation, and exhibit decreased expression of the cell differentiation marker P0 protein; hyperproliferating cells develop after a 1-week lag in Schwann cells heterozygous at Nf1. The experiments suggest that events subsequent to Nf1 mutations are required for development of Schwann cell hyperplasia. Finally, an anti-Ras farnesyl protein transferase inhibitor greatly diminished both clone formation and hyperproliferation of null mutant cells, but not invasion; farnesyl transferase inhibitors could be useful in treating benign manifestations of NF1.
Similar articles
- Gene-targeted deletion of neurofibromin enhances the expression of a transient outward K+ current in Schwann cells: a protein kinase A-mediated mechanism.
Xu Y, Chiamvimonvat N, Vázquez AE, Akunuru S, Ratner N, Yamoah EN. Xu Y, et al. J Neurosci. 2002 Nov 1;22(21):9194-202. doi: 10.1523/JNEUROSCI.22-21-09194.2002. J Neurosci. 2002. PMID: 12417644 Free PMC article. - Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V. Yan N, et al. Cancer Res. 1995 Aug 15;55(16):3569-75. Cancer Res. 1995. PMID: 7627966 - Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
Badache A, Muja N, De Vries GH. Badache A, et al. Oncogene. 1998 Aug 13;17(6):795-800. doi: 10.1038/sj.onc.1201978. Oncogene. 1998. PMID: 9715282 - Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Rosenbaum T, Kim HA, Boissy YL, Ling B, Ratner N. Rosenbaum T, et al. Ann N Y Acad Sci. 1999 Sep 14;883:203-14. Ann N Y Acad Sci. 1999. PMID: 10586246 - Tissue culture studies of Schwann cell proliferation and differentiation.
Pleasure D, Kreider B, Shuman S, Sobue G. Pleasure D, et al. Dev Neurosci. 1985;7(5-6):364-73. doi: 10.1159/000112303. Dev Neurosci. 1985. PMID: 2424706 Review.
Cited by
- C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N. Perrino MR, et al. Life Sci Alliance. 2024 Mar 8;7(5):e202302229. doi: 10.26508/lsa.202302229. Print 2024 May. Life Sci Alliance. 2024. PMID: 38458648 Free PMC article. - Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.
Reiners JJ Jr, Mathieu PA, Gargano M, George I, Shen Y, Callaghan JF, Borch RF, Mattingly RR. Reiners JJ Jr, et al. Cancers (Basel). 2023 Dec 23;16(1):89. doi: 10.3390/cancers16010089. Cancers (Basel). 2023. PMID: 38201517 Free PMC article. - Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
Kershner LJ, Choi K, Wu J, Zhang X, Perrino M, Salomonis N, Shern JF, Ratner N. Kershner LJ, et al. JCI Insight. 2022 Sep 22;7(18):e154513. doi: 10.1172/jci.insight.154513. JCI Insight. 2022. PMID: 36134665 Free PMC article. - Malignant peripheral nerve sheath tumor: models, biology, and translation.
Somatilaka BN, Sadek A, McKay RM, Le LQ. Somatilaka BN, et al. Oncogene. 2022 Apr;41(17):2405-2421. doi: 10.1038/s41388-022-02290-1. Epub 2022 Apr 7. Oncogene. 2022. PMID: 35393544 Free PMC article. Review. - RAS and beyond: the many faces of the neurofibromatosis type 1 protein.
Anastasaki C, Orozco P, Gutmann DH. Anastasaki C, et al. Dis Model Mech. 2022 Feb 1;15(2):dmm049362. doi: 10.1242/dmm.049362. Epub 2022 Feb 21. Dis Model Mech. 2022. PMID: 35188187 Free PMC article.
References
- Science. 1993 Nov 12;262(5136):1065-9 - PubMed
- Science. 1993 Nov 12;262(5136):1069-72 - PubMed
- Cardiovasc Res. 1993 Jul;27(7):1155-61 - PubMed
- Exp Cell Res. 1993 Dec;209(2):224-30 - PubMed
- Genes Chromosomes Cancer. 1994 Aug;10(4):250-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous